Amanda Rush/LinkedIn
Dec 22, 2025, 22:34
Amanda Rush and Other Researchers Spoke with 87 Australians Affected by a Range of Blood Disorders
Haemophilia Foundation Australia shared a post on LinkedIn:
“Gene therapies are creating new hope for people with serious conditions like haemophilia. These treatments can be life-changing, but they also raise important questions: how should we pay for them, who should have access, and what happens when the long-term effects are still uncertain?
In the latest issue of National Haemophilia, Amanda Rush and other researchers spoke with 87 Australians affected by a range of blood disorders as part of a study led by the University of Sydney.
Thanks to the people and parents of children with haemophilia who participated in this research.
Read the results.”
Stay informed with latest blood disorders updates on Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?